The University of Melbourne has announced an agreement with Bio Farma, a leading vaccine company, to develop an adjuvant, a vaccine delivery system, which could boost the effectiveness of vaccines for a range of infectious diseases including Hepatitis C, Diphtheria, Tetanus, Pertussis, Hepatitis B and Haemopilus influenza type B.